|
| |
Funding For Development Of OSU Technologies
May 17, 2008 -- OSU's Technology Business Assessment Group will fund four faculty research projects for spring 2008. The group identified these one-year projects from a number of excellent proposals submitted in response to a solicitation earlier this spring. Funding for the program is administered by the OSU Office of Intellectual Property Management, and is generated by royalties from OSU-licensed technologies. These funded projects show a significant probability of having commercial success.
|
Australian Metabolic Syndrome Research Project Receives Grant From International Diabetes Federation
May 17, 2008 -- The International Diabetes Federation (IDF) BRIDGES translational research grant program will fund STOP Diabetes, a project to be implemented and studied in Australia. The STOP project is designed to reduce the risk for type 2 diabetes in women by encouraging healthy behaviours.
|
Analysis: Control Reduces Cardiovascular Risk By 42%
May 17, 2008 -- Results of a new analysis of the Treating to New Targets (TNT) study show that intensive low-density lipoprotein (LDL) cholesterol-lowering in patients with stable coronary heart disease (CHD) whose systolic blood pressure was less than 140 mmHg reduced the risk of major cardiovascular events, including heart attack, stroke and resuscitated cardiac arrest, by 42 percent compared with less intensive LDL lowering and uncontrolled blood pressure of 140 mmHg or higher.Led by John B.
|
Analysis: Control Reduces Cardiovascular Risk By 42%
May 17, 2008 -- Results of a new analysis of the Treating to New Targets (TNT) study show that intensive low-density lipoprotein (LDL) cholesterol-lowering in patients with stable coronary heart disease (CHD) whose systolic blood pressure was less than 140 mmHg reduced the risk of major cardiovascular events, including heart attack, stroke and resuscitated cardiac arrest, by 42 percent compared with less intensive LDL lowering and uncontrolled blood pressure of 140 mmHg or higher.Led by John B.
|
Prospective Study Of The Long-Term Effects Of Shock Wave Lithotripsy On Renal Function And Blood Pressure
May 17, 2008 -- UroToday.com - The debate regarding the long-term effects of SWL on patient hypertension and diabetes continues.These researchers from Egypt prospectively randomized 100 patients with a single, 2 cm or less renal stone and similar BMI's, treated with unilateral SWL on an electrohydraulic (Dornier MFL 5000) or an electromagnetic (Dornier Lithotripter S) lithotripter unit.
|
Boston Scientific Announces FDA Approval Of New Heart Failure Lead
May 17, 2008 -- Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration (FDA) approval of its ACUITY(R) Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators (CRT-D) and cardiac resynchronization therapy pacemakers (CRT-P), both of which treat heart failure. The ACUITY Spiral lead is the Company's fifth generation left ventricular lead and second in the ACUITY family of left ventricular leads.
|
Questioning The Risk Of Death From Higher Salt Intake
May 17, 2008 -- Contrary to long-held assumptions, high-salt diets may not increase the risk of death, according to investigators from the Albert Einstein College of Medicine of Yeshiva University. They reached their conclusion after examining dietary intake among a nationally representative sample of adults in the U.S. The Einstein researchers actually observed a significantly increased risk of death from cardiovascular disease (CVD) associated with lower sodium diets.
|
ACP, ACP Foundation Diabetes Initiative Plans For 2 More Years
May 17, 2008 -- The Diabetes Initiative of the American College of Physicians (ACP) and the ACP Foundation released new information on the first three years of its project to improve diabetes care primarily through special efforts targeting physicians' practices.The Initiative was funded in 2005 by an unrestricted educational grant from Novo Nordisk, Inc.
|
Questioning The Risk Of Death From Higher Salt Intake
May 17, 2008 -- Contrary to long-held assumptions, high-salt diets may not increase the risk of death, according to investigators from the Albert Einstein College of Medicine of Yeshiva University. They reached their conclusion after examining dietary intake among a nationally representative sample of adults in the U.S. The Einstein researchers actually observed a significantly increased risk of death from cardiovascular disease (CVD) associated with lower sodium diets.
|
Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions In Blood Pressure In Hypertensive Patient
May 17, 2008 -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced that PS433540, its first-in-class Dual Acting Receptor Antagonist (DARA), showed statistically significant blood pressure reductions in a Phase 2a study in patients with mild to moderate hypertension.
|
|